Paul de Souza
- Oncology top 0.5%
- Cancer Cells and Metastasis 19
- Cancer Immunotherapy and Biomarkers 18
- Colorectal Cancer Treatments and Studies 16
- Genetics top 1%
- Glioma Diagnosis and Treatment 10
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 27
-
- Prostate Cancer Treatment and Research 17
- Renal cell carcinoma treatment 13
- Immunology top 5%
-
- Genetic factors in colorectal cancer 11
- Co-authors
- Martina H. StenzelMaciej KrzakowskiGladys UrbanowitzVera HirshDavid GordonTherese M. BeckerLee S. RosenMing Zheng
- Cited by
- OncologyGeneticsCancer Research
- Journals
- Journal of Clinical Oncology (7 papers)SHILAP Revista de lepidopterología (5 papers)PLoS ONE (6 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Paul de Souza
147 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Oncology 3.2k
- Genetics 939
- Cancer Research 1.3k
- Pulmonary and Respiratory Medicine 2.1k
- Immunology 813
Countries citing papers authored by Paul de Souza
This map shows the geographic impact of Paul de Souza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul de Souza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul de Souza more than expected).
Fields of papers citing papers by Paul de Souza
This network shows the impact of papers produced by Paul de Souza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul de Souza. The network helps show where Paul de Souza may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul de Souza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 1 | |
| 4 | Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors | 2022 | 40 |
| 5 | 2022 | 11 | |
| 6 | 2021 | 43 | |
| 7 | 2021 | 0 | |
| 8 | 2020 | 14 | |
| 9 | 2020 | 33 | |
| 10 | 2020 | 3 | |
| 11 | 2020 | 22 | |
| 12 | 2019 | 2 | |
| 13 | 2018 | 23 | |
| 14 | 2018 | 19 | |
| 15 | 2016 | 1 | |
| 16 | 2014 | 187 | |
| 17 | 2013 | 134 | |
| 18 | 2013 | 27 | |
| 19 | 2013 | 82 | |
| 20 | 2012 | 53 |
About Paul de Souza
Paul de Souza is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 152 papers that have together received 6.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (27 papers), Cancer Cells and Metastasis (19 papers), Cancer Immunotherapy and Biomarkers (18 papers), Prostate Cancer Treatment and Research (17 papers), Colorectal Cancer Treatments and Studies (16 papers), Renal cell carcinoma treatment (13 papers), Genetic factors in colorectal cancer (11 papers) and Glioma Diagnosis and Treatment (10 papers). The work is most often cited by research in Oncology (3.2k citations), Genetics (939 citations) and Cancer Research (1.3k citations). Paul de Souza has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Martina H. Stenzel, Maciej Krzakowski, Gladys Urbanowitz, Vera Hirsh, David Gordon, Therese M. Becker, Lee S. Rosen, Ming Zheng, Ronald Yanagihara and Marek Pawlicki. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.